Published in J Nucl Med on December 01, 1992
Development of (99m)Tc-N4-NIM for molecular imaging of tumor hypoxia. J Biomed Biotechnol (2012) 0.75
Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. J Nucl Med (2000) 2.17
[A case of chronic pulmonary hypertension after fenfluramine intake]. Wien Klin Wochenschr (1982) 1.72
AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell (2001) 1.60
Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol (1996) 1.49
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv (2001) 1.44
201Tl as a tumour-localizing agent: current status and future considerations. Nucl Med Commun (1993) 1.43
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts. Catheter Cardiovasc Interv (1999) 1.39
Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes. Scand J Immunol (1991) 1.39
"Clinical PET: its time has come?". J Nucl Med (1993) 1.39
Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism. Nature (1983) 1.37
Imaging of bone metastases with 99m Tc-Sn-EHDP (diphosphonate), 18 F, and skeletal radiography. A comparison of sensitivity. Radiology (1973) 1.30
Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol (2006) 1.25
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med (2001) 1.25
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene (2007) 1.23
The Lugano statements on controlled clinical trials. J Int Med Res (1987) 1.23
Control of Drosophila head segment identity by the bZIP homeotic gene cnc. Development (1995) 1.19
Reactions of cobalt(I) supernucleophiles. The alkylation of vitamin B12s cobaloximes(I), and related compounds. J Am Chem Soc (1969) 1.15
Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest (1998) 1.14
Fibrosing mediastinitis causing nonvisualization of one lung on pulmonary scintigraphy. Clin Nucl Med (1993) 1.13
Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med (1989) 1.10
Successful storage of RBCs for 10 weeks in a new additive solution. Transfusion (2000) 1.10
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy. Ann Oncol (2007) 1.09
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun (2007) 1.09
Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med (1995) 1.06
A "do it yourself" family care program. Ohio State Med J (1971) 1.06
Kinetics of endothelial cell seeding. J Vasc Surg (1985) 1.06
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol (2011) 1.04
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int (2000) 1.04
'VIT1', a novel gene associated with vitiligo. Pigment Cell Res (2001) 1.01
Spontaneous spinal epidural hematoma with spinal cord compression complicating plasma cell myeloma. A case report. Spine (Phila Pa 1976) (1998) 1.01
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B (1986) 0.99
Letter: Reverse transcriptase in plasma of patients with breast cancer. Lancet (1974) 0.98
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol (1999) 0.98
Buffering and dilution in red blood cell storage. Transfusion (2006) 0.97
Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med (1997) 0.96
Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies. Immunol Rev (1986) 0.96
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol (2001) 0.96
The nucleophilicity of vitamin B12. J Am Chem Soc (1968) 0.95
Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect? Ann Oncol (2011) 0.94
Radiobiological evaluation of immigrants from the vicinity of Chernobyl. Int J Radiat Biol (1997) 0.94
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer (2007) 0.93
The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol (2000) 0.93
PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim (2000) 0.93
Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. Cancer Res (1980) 0.92
Using mobile clinics to deliver HIV testing and other basic health services in rural Malawi. Rural Remote Health (2011) 0.92
Carcinosarcoma of the nose and paranasal sinuses-a case report. Rhinology (1982) 0.91
The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun (2010) 0.91
T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemost (1983) 0.90
Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective? Cleve Clin J Med (1996) 0.90
Reverse redistribution phenomenon in thallium-201 stress tests: angiographic correlation and clinical significance. J Nucl Med (1985) 0.89
Caspase independence of radio-induced cell death. Oncogene (2006) 0.89
Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead. Br J Cancer (2012) 0.89
Uptake of trimethoprim by renal cortex. Biochem Pharmacol (1985) 0.89
Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate). J Med Chem (1996) 0.89
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma. Cell Prolif (2009) 0.89
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer (2000) 0.89
Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects. Ther Drug Monit (1982) 0.89
Lymphoid papillary hyperplasia of the palatine tonsils. Am J Surg Pathol (1983) 0.88
Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12. J Nucl Med (1994) 0.87
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene (2003) 0.87
DnrD cyclase involved in the biosynthesis of doxorubicin: purification and characterization of the recombinant enzyme. Biochemistry (1999) 0.87
Isolated right superior vena cava draining into left atrium diagnosed by radionuclide angiocardiography. J Nucl Med (1973) 0.86
[Causal therapeutic management of aplastic anaemia (author's transl)]. Wien Klin Wochenschr (1981) 0.86
[The effect of raubasine on the vein tonus and venous capacity of the lower leg]. Z Kreislaufforsch (1968) 0.86
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. Invest New Drugs (2012) 0.86
67Ga as a diagnostic agent for the detection of head and neck tumors and lymphoma. Radiology (1974) 0.86
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer (2001) 0.86
A case of elevated spontaneous micronucleus frequency derived from chromosome 2. Mutat Res (1999) 0.85
Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. Int J Cancer (2000) 0.85
Increased gut blood flow with early enteral feeding in burned guinea pigs. J Burn Care Rehabil (1989) 0.85
Expression of salt and urea transporters in rat kidney during cisplatin-induced polyuria. Kidney Int (2001) 0.85
The effect of fibronectin coating on endothelial cell kinetics in polytetrafluoroethylene grafts. J Vasc Surg (1986) 0.85
Strontium-89 therapy for the pain of osseous metastases. J Nucl Med (1985) 0.85
Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication. J Nucl Med (1984) 0.84
Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft. Surgery (1987) 0.84
External fixation using microplates after laryngotracheal expansion surgery. An animal study. Arch Otolaryngol Head Neck Surg (1991) 0.84
Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy. Int J Clin Pharmacol Ther Toxicol (1981) 0.84
In vivo renal tubular secretion of trimethoprim without metabolism. Biochem Pharmacol (1987) 0.84
n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer (2003) 0.84
Clinical significance of serum vitamin B12 measured by radioassay using pure intrinsic factor. J Nucl Med (1981) 0.84
[A simple method for the preparation of human factor VII-deficient plasma]. Thromb Diath Haemorrh (1967) 0.84
Quantification of renal uric acid synthesis in the rat. Am J Physiol (1980) 0.84
99mTc(L-L)3+ complexes containing ether analogs of DMPE. Nucl Med Biol (1999) 0.83
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med (1993) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Selective thrombin inhibitors: the next generation of anticoagulants. J Am Coll Cardiol (1993) 0.83
Radionuclide imaging. Use in diagnosis of osteomyelitis in children. JAMA (1977) 0.83
Idiopathic pulmonary ossification with focal pulmonary uptake of technetium-99m HMDP bone scanning agent. Clin Nucl Med (1985) 0.83
Xerostomia--diagnosis and treatment. Oral Surg Oral Med Oral Pathol (1981) 0.83
Acute otitis media in the first two months of life: characteristics and diagnostic difficulties. Arch Dis Child (2008) 0.83
Thyroglossal duct carcinomas: light and electron microscopic studies. Head Neck Surg (1986) 0.83
Effect of thyroid hormones on plasma protein concentrations in man. J Clin Endocrinol Metab (1986) 0.82
The value of hepatobiliary scans in fasted patients receiving total parenteral nutrition. Surgery (1987) 0.82
Biologic augmentation of polymer scaffolds for bone repair. J Musculoskelet Neuronal Interact (2007) 0.82
An evaluation of undergraduate family care programs. J Community Health (1978) 0.82
Carotid endarterectomy in patients 55 years of age and younger. Ann Vasc Surg (2001) 0.81